Ovulation induction and early pregnancy loss in a woman susceptible to autoimmune diseases: A possible interrelationship

Gynecological Endocrinology

Volumn 14, Issue 3, 2000, Pages 153-157

  Macut, Dj ^a,d   Micic D ^a   Suvajdzic N ^b   Sumarac M ^a   Kendereski A ^a   Zoric S ^a   Elezovic I ^b   Petrovic R ^c   Cvijovic G ^a   Gligorovic P ^a  

^a INSTITUTE OF ENDOCRINOLOGY

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c INSTITUTE OF RHEUMATOLOGY   (Serbia)

^d INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Antiphospholipid syndrome; Autoimmune disease; Erythematosus; Insulin dependent diabetes mellitus; Ovulation induction; Systemic lupus

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DISEASE PREDISPOSITION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

EID: 0033936916     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513590009167675     Document Type: Article

References (17)

1. 1. Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthr Rheumatol 1994;37:1614-17
2. 2. Le Thi Huong D, Wechsler B, Piette J-C, et al. Risks of ovulation-induction therapy in systemic lupus erythematosus. Br J Rheumatol 1996;35: 1184-6
3. 3. Bronson R. Immunology and reproductive medicine. Hum Reprod 1995;10:755-7
4. 4. Kutteh WH. Antiphospholipid antibodies and reproduction. J Reprod Immunol 1997;35:151-71
5. 5. Boddi M, Prisco D, Fedi S, et al. Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes. Thromb Res 1996;82:207-16
6. 6. Le Thi Huong D, Wechsler B, Piette J-C, et al. Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 1994;87:721-9
7. 7. Jungers P, Dougados M, Pélissier C, et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthr Rheumatol 1982;25:618-23
8. 8. Lahita RG, Bradlow L, Fishman J. Increased 16β-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981;53: 174-8
9. 9. Meirow D, Laufer N, Schenker JG. Ovulation induction and in vitro fertilization. Gynecol Endocrinol 1993;6:211-24
10. 10. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9
11. 11. Rand JH, Wu X-X, Andree HAM, et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997;337:154-60
12. 12. Verthelyi D, Ansar Ahmed S. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J Autoimmun 1997;10: 115-25
13. 13. Seisdedos L, Munoz-Rodriguez FJ, Cervera R, et al. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus 1997;6: 285-6
14. 14. Gaspard UJ, Lefebvre PJ. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am J Obstet Gynecol 1990;163:334-43
15. 15. Stevenson JC, Crook D, Godsland IF, et al. Oral versus transdermal hormone replacement therapy. Int J Fertil Menop Stud 1993;38:30-5
16. 16. Maman E, Lunenfeld E, Levy A, et al. Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 1998;70:240-5
17. 17. Fischer K. A rapid evolution mechanism may contribute to changes in sex ratio, multiple birth incidence, frequency of auto-immune disease and frequency of birth defects in Clomid conceptions. Med Hypotheses 1990;31:59-65